NASDAQ:AKTX
Akari Therapeutics Plc Stock News
$1.87
+0.0050 (+0.269%)
At Close: Mar 28, 2024
Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress
09:00am, Friday, 11'th Dec 2020
NEW YORK and LONDON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and
NEW YORK and LONDON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and
NEW YORK and LONDON, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammator
NEW YORK and LONDON, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammator
UK lawmakers accuse Huawei of 'collusion' with Beijing, say telco's gear may be axed from British networks by 2025
07:59am, Thursday, 08'th Oct 2020
In July, the U.K. government announced that mobile network operators in the country would need to rip out Huawei gear from their infrastructure by 2027. Now lawmakers say that might need to happen by
* Phase III randomized placebo-controlled study in moderate to severe bullous pemphigoid (BP) patients with a primary endpoint of complete disease remission on minimal oral corticosteroids (OCS) agree
Global Paroxysmal Nocturnal Hemoglobinuria Pipeline Monitor, 2020 - ResearchAndMarkets.com
12:00am, Tuesday, 04'th Aug 2020
The
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
Akari Therapeutics (NASDAQ:AKTX) vs. Cellectar Biosciences (NASDAQ:CLRB) Head-To-Head Survey
01:54am, Sunday, 19'th Jul 2020
Cellectar Biosciences (NASDAQ:CLRB) and Akari Therapeutics (NASDAQ:AKTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength
Akari Therapeutics Enters into a Securities Purchase Agreement for up to $30 Million with Aspire Capital Fund, LLC
01:16pm, Wednesday, 01'st Jul 2020
NEW YORK and LONDON, July 01, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (“Akari” or the “Company”) (AKTX), a biopharmaceutical company focused on the development and commercializat
Akari Therapeutics Announces Appointment of Chief Financial Officer
01:15pm, Wednesday, 01'st Jul 2020
NEW YORK and LONDON, July 01, 2020 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (“Akari” or the “Company”) (AKTX), a biopharmaceutical company focused on the development and commercializat
3 Biotech Stocks Under $5 With 100%-Plus Upside Potential
03:23pm, Thursday, 25'th Jun 2020
Biotech stocks give a whole new meaning to risk/reward plays. Unlike names inhabiting other areas of the market, these tickers can witness explosive movements in the blink of an eye, giving them a Str
Top Analysts See 100%-Plus Upside Potential in These 3 Penny Stocks
06:27am, Thursday, 25'th Jun 2020
Penny stocks give a whole new meaning to risk/reward plays. These tickers can witness explosive movements in the blink of an eye, giving them a Street
Alexion Announces Phase 3 Study of Weekly Subcutaneous ULTOMIRIS® (ravulizumab-cwvz) Met Primary Endpoint
12:00am, Wednesday, 24'th Jun 2020
Alexion Announces Phase 3 Study of Weekly Subcutaneous ULTOMIRIS® (ravulizumab-cwvz) Met Primary Endpoint.
Akari Therapeutics: An Investment Assessment (NASDAQ:AKTX)
07:09am, Tuesday, 16'th Jun 2020
This week, we take an in-depth look at sparsely followed Akari Therapeutics. The company is taking an unusual route to develop treatments of rare and orphan dis